ARCA biopharma Release: Gencaro™ Potential Efficacy in Preventing Atrial Fibrillation Paper Published in JACC: Heart Failure
6/6/2013 10:12:01 AM
More...
|
ARCA biopharma Announces Closing of $20 Million Equity Offering
6/5/2013 9:53:22 AM
More...
|
ARCA biopharma Announces Pricing of $20 Million Equity Offering
5/30/2013 10:48:44 AM
More...
|
ARCA biopharma Announces Death of Board Member Burton E. Sobel, Preeminent Physician Scientist and Academic Leader
5/7/2013 7:56:34 AM
More...
|
ARCA biopharma, Medtronic, Inc. (MDT) Collaborate on Atrial Fibrillation Trial
4/22/2013 8:06:01 AM
More...
|
ARCA biopharma Announces Reverse Stock Split
3/5/2013 9:38:26 AM
More...
|
ARCA biopharma Release: Unmet Medical Need in Treatment of Heart Failure Patients With Atrial Fibrillation Highlighted in Articles in Inaugural Issue of JACC: Heart Failure
2/7/2013 9:39:45 AM
More...
|
ARCA biopharma Release: New Adaptive Phase 3 Trial Planned for Gencaro™ in Atrial Fibrillation
1/30/2013 9:51:26 AM
More...
|
ARCA biopharma Release: Gencaro™ Effect on Reducing Ventricular Arrhythmias Paper Published in Circulation: Arrhythmia and Electrophysiology
1/3/2013 9:42:52 AM
More...
|
ARCA biopharma Release: Gencaro™ Cardiovascular Effect on Patients With Atrial Fibrillation Paper Published in European Journal of Heart Failure
12/12/2012 11:33:13 AM
More...
|
|